Elutia Inc Ordinary Shares - Class A ELUT

Morningstar Rating
$0.84 +0.02 (2.44%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ELUT is trading at a LOCK|Xrgyd premium.
Price
$0.82
Fair Value
LOCK|>?y>tj
Uncertainty
LOCK|^z NH>w
1-Star Price
LOCK|@#$!#T
5-Star Price
LOCK|Nl@V&#
Economic Moat
LOCK|DL
Capital Allocation
—

News

Trading Information

Previous Close Price
$0.82
Day Range
$0.82–0.84
52-Week Range
$0.50–1.39
Bid/Ask
$0.81 / $0.85
Shares Outstanding
44.40M
Market Cap
$37.29M
Volume/Avg
39,710 / 182,915

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
5.57
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Dividend Payment Schedule
—
Total Yield
< 0.01%

Company Profile

Elutia Inc develops proprietary drug-eluting biomatrix products for use in surgical reconstruction and related applications. These products are designed to improve the interaction between implanted medical devices and patients. Its products include CanGaroo, designed for implantable electronic devices, and SimpliDerm, used in soft tissue repair, with functions related to implant support and wound management. The company operates in two segments: Women's Health and Cardiovascular. The majority of revenue is derived from the Women's Health segment.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
26

Valuation

Metric
ELUT
Price/Earnings (Normalized)
—
Price/Book Value
2.38
Price/Sales
5.57
Price/Cash Flow
—
Price/Earnings
No chart available

Financial Strength

Metric
ELUT
Quick Ratio
2.56
Current Ratio
2.63
Interest Coverage
—
Quick Ratio
ELUT

Profitability

Metric
ELUT
Return on Assets (Normalized)
−180.17%
Return on Equity (Normalized)
−1,151.89%
Return on Invested Capital (Normalized)
−468.49%
Return on Assets
ELUT

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|$G?^crtLOCK|QS@q@$188B
Medtronic PLC
MDT
LOCK|R!>^<$LOCK|TrR$$132B
Stryker Corp
SYK
LOCK|$rxwwFBmLOCK|H^$118B
Boston Scientific Corp
BSX
LOCK|Z?V#$>qLOCK|&LVy$64B
Edwards Lifesciences Corp
EW
LOCK|Y>w&^!pLOCK|$h#c$62B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|bg<DFvcLOCK|NBq$38B
DexCom Inc
DXCM
LOCK|Y?!$xMq#LOCK|mK&P$31B
Koninklijke Philips NV ADR
PHG
LOCK|>GLOCK|t&$30B
Steris PLC
STE
LOCK|Y#>%Z<LOCK|>QGf$26B
Zimmer Biomet Holdings Inc
ZBH
LOCK|?!JR^j!LOCK|#j$20B

Sponsor Center